Fennec Pharmaceuticals (FENC) Other Non Operating Income (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Other Non Operating Income of -$2.0 million for Q4 2025, down 68200.0% on a QoQ basis from -$3000.0 in Q3 2025, and down 7488.89% year-over-year from $27730.8 in Q4 2024.
Fennec Pharmaceuticals (FENC) Other Non Operating Income (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Other Non Operating Income history runs 16 years deep, the most recent figure standing at -$2.0 million for Q4 2025.
- Quarterly Other Non Operating Income fell 7488.89% year-over-year to -$2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (down 2365.85% YoY) and the FY2025 annual result came in at -$2.0 million, down 2365.85% from the prior year.
- Other Non Operating Income was -$2.0 million for Q4 2025 at Fennec Pharmaceuticals, down from -$3000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $17000.0 in Q2 2025 and bottomed at -$2.0 million in Q4 2025.
- A 5-year average of -$111473.7 and a median of -$3000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 400.0% — and 2025, when it sank 7488.89%.
- Fennec Pharmaceuticals' Other Non Operating Income stood at -$1000.0 in 2021, then plunged by 200.0% to -$3000.0 in 2022, then jumped by 166.67% to $2000.0 in 2023, then slumped by 1450.0% to -$27000.0 in 2024, then sank by 7488.89% to -$2.0 million in 2025.
- Business Quant data shows FENC's Other Non Operating Income at -$2.0 million in Q4 2025, -$3000.0 in Q3 2025, and $17000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | -5,000.00 |